Marvin & Palmer Associates’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
2023
Q2
$9.8M Buy
2023
Q1
$2.06M Sell
2022
Q4
$1.77M Buy